The House Energy and Commerce Committee passed 15 health-related bills approved by its health subcommittee last week, including bills that would reauthorize the Pandemic and All-Hazards Preparedness Act, Children’s Hospitals Graduate Medical Education Program, and key programs within the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act.  
 
The PAHPA reauthorization bills (H.R. 4421 and H.R. 4420) passed along party lines, with Democrats objecting to a lack of provisions to address drug shortages. The CHGME bill (H.R. 3887), also passed without Democratic support, would reauthorize payments to children’s hospitals that operate Graduate Medical Education programs for fiscal years 2024 through 2028 and prohibit payments to CHGME recipients that furnish gender-affirming procedures or drugs for minors. The Support for Patients and Communities Reauthorization Act (H.R. 4531), which passed with bipartisan support, would reauthorize key SUPPORT Act programs for patients with substance use disorder and permanently extend required Medicaid coverage for medication-assisted treatments. As amended and urged by the AHA, the bill also would permanently extend the option for state Medicaid programs to receive federal matching payments for SUD treatment provided in certain Institutions for Mental Disease for up to 30 days over a 12-month period. 

Related News Articles

Headline
The Food and Drug Administration July 31 announced that it is requiring safety label changes to all opioid pain medications to further emphasize and explain…
Headline
The Senate Appropriations Committee July 31 advanced the fiscal year 2026 appropriations bill for the Departments of Labor, Health and Human Services,…
Chairperson's File
Public
The recently enacted One Big Beautiful Bill Act will bring big changes to health care. AHA President and CEO Rick Pollack joined me for a Leadership Dialogue…
Headline
The Congressional Budget Office today released its estimate of the budgetary effects of the One Big Beautiful Bill Act, as enacted. CBO projects the law will…
Headline
The Centers for Medicare & Medicaid Services July 17 issued two letters to states regarding policies on continuous eligibility and workforce initiatives.…
Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…